Claudio Fiocchi
#113,448
Most Influential Person Now
Claudio Fiocchi's AcademicInfluence.com Rankings
Claudio Fiocchimedical Degrees
Medical
#1576
World Rank
#1928
Historical Rank
Gastroenterology
#22
World Rank
#23
Historical Rank
Claudio Fiocchiphilosophy Degrees
Philosophy
#4836
World Rank
#7493
Historical Rank
Logic
#2210
World Rank
#3154
Historical Rank
Download Badge
Medical Philosophy
Claudio Fiocchi's Degrees
- Doctorate Medicine University of Milan
Why Is Claudio Fiocchi Influential?
(Suggest an Edit or Addition)Claudio Fiocchi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Inflammatory bowel disease: etiology and pathogenesis. (1998) (2129)
- Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. (1996) (1267)
- Immunopathogenesis of IBD: current state of the art (2016) (955)
- Environmental triggers in IBD: a review of progress and evidence (2018) (447)
- Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. (1995) (418)
- Inflammatory bowel disease: the role of environmental factors. (2004) (398)
- Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. (2001) (377)
- Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. (1999) (372)
- Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. (2006) (368)
- Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis (2010) (367)
- Ulcerative colitis. (2011) (350)
- Etiopathogenesis of inflammatory bowel diseases. (2006) (285)
- VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. (2009) (285)
- Intestinal fibrosis in IBD—a dynamic, multifactorial process (2009) (282)
- Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation1 (2007) (279)
- Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. (2011) (265)
- Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. (2017) (264)
- Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients (2003) (254)
- The IBD interactome: an integrated view of aetiology, pathogenesis and therapy (2017) (253)
- Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications (2004) (238)
- A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. (2003) (212)
- Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. (2003) (205)
- Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. (1997) (201)
- Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. (1993) (201)
- Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease (2007) (194)
- The emergence of inflammatory bowel disease in the Asian Pacific region (2005) (192)
- Cutting Edge: T Cells Trigger CD40-Dependent Platelet Activation and Granular RANTES Release: A Novel Pathway for Immune Response Amplification1 (2004) (185)
- Inclusion of the Mesentery in Ileocolic Resection for Crohn’s Disease is Associated With Reduced Surgical Recurrence (2018) (178)
- Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. (1997) (174)
- VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. (2014) (170)
- Inflammatory bowel disease: Progress and current concepts of etiopathogenesis (2007) (158)
- The CD40/CD40L costimulatory pathway in inflammatory bowel disease (2004) (148)
- Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease (2001) (143)
- Mucosal immunity and inflammation (1989) (142)
- Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. (2007) (139)
- TNF-α Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn’s Disease1 (2006) (137)
- Intestinal fibrosis in inflammatory bowel disease - Current knowledge and future perspectives. (2008) (135)
- Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients. (1986) (133)
- Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide (1994) (133)
- Interleukin 4 in inflammatory bowel disease and mucosal immune reactivity. (1996) (132)
- Challenges in pediatric inflammatory bowel disease. (2006) (129)
- Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy (2010) (128)
- Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. (1984) (122)
- Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. (2009) (117)
- Angiogenesis blockade as a new therapeutic approach to experimental colitis (2006) (115)
- Phenotypic analysis of lamina propria lymphocytes (1986) (114)
- Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease (1998) (113)
- New isolation technique to study apoptosis in human intestinal epithelial cells. (1998) (113)
- Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease. (2012) (112)
- Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. (2005) (111)
- An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial. (2005) (111)
- Management consensus of inflammatory bowel disease for the Asia–Pacific region (2006) (110)
- T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. (2014) (110)
- American Journal of Physiology: Gastrointestinal and Liver Physiology American Journal of Physiology: Heart and Circulatory Physi- QlQgY American Journal of Physiology: Regulatory, Integrative and Comparative Physiology American Journal of Physiology: Renal, Fluid and Electrolyte (2003) (108)
- Signal Transducers and Activators of Transcription 3 Signaling Pathway: An Essential Mediator of Inflammatory Bowel Disease and Other Forms of Intestinal Inflammation (2005) (104)
- Proinflammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. (1998) (103)
- A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 (2020) (102)
- Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis (1999) (100)
- A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. (2016) (99)
- Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis (2004) (98)
- Themes in fibrosis and gastrointestinal inflammation. (2011) (97)
- TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. (2001) (95)
- Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. (1998) (95)
- TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. (2006) (94)
- Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesis. (2013) (93)
- Immune activation genes in inflammatory bowel disease. (1993) (92)
- Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis? (2004) (90)
- Proinflammatory cytokines alter/reduce esophageal circular muscle contraction in experimental cat esophagitis. (2004) (90)
- Intestinal immunity and inflammation: recent progress. (1986) (88)
- CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. (2004) (85)
- Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls. (1989) (84)
- High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives. (1989) (82)
- Etiopathogenesis of Inflammatory Bowel Disease: The Importance of the Pediatric Perspective (2002) (80)
- Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. (1985) (78)
- Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation (2018) (78)
- Critical role of the CD40–CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease (2007) (78)
- Hyaluronan (HA) Deposition Precedes and Promotes Leukocyte Recruitment in Intestinal Inflammation (2008) (76)
- Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. (1997) (75)
- Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. (1991) (75)
- Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. (2014) (74)
- Disparate CD4+ Lamina Propria (LP) Lymphokine Secretion Profiles in Inflammatory Bowel Disease: 518 (1997) (74)
- Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro. (1985) (74)
- Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis? (2004) (72)
- Immunoregulatory function of lamina propria T cells in Crohn's disease. (1985) (72)
- Transforming growth factor‐β1 preserves epithelial barrier function: Identification of receptors, biochemical intermediates, and cytokine antagonists (1999) (69)
- Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. (2007) (68)
- Handbook of mucosal immunology (1994) (65)
- Corticotropin-releasing hormone family of peptides regulates intestinal angiogenesis. (2010) (65)
- Interferon gamma production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. (1988) (64)
- Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. (1992) (64)
- Inflammatory bowel disease pathogenesis: Where are we? (2015) (63)
- IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis (2014) (61)
- Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. (2001) (60)
- Intestinal epithelial cells contribute to the enhanced generation of platelet activating factor in ulcerative colitis. (1993) (57)
- Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. (2005) (57)
- Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. (2004) (56)
- Pathogenesis of inflammatory bowel disease. (1999) (55)
- Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease (1992) (54)
- Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science (2008) (54)
- Review article: breath analysis in inflammatory bowel diseases (2015) (54)
- The epithelial danger signal IL-1α is a potent activator of fibroblasts and reactivator of intestinal inflammation. (2015) (53)
- Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization. (1979) (52)
- Inhibition of IFN-gamma activity in supernatants from stimulated human intestinal mononuclear cells prevents up-regulation of the polymeric Ig receptor in an intestinal epithelial cell line. (1994) (52)
- p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling. (2002) (51)
- Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. (2008) (51)
- Interleukin 1β-Induced Production of H2O2 Contributes to Reduced Sigmoid Colonic Circular Smooth Muscle Contractility in Ulcerative Colitis (2004) (50)
- Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease. (1983) (50)
- HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells. (2012) (49)
- A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19 (2020) (49)
- CD4 positive Leu-8 negative helper-inducer T cells predominate in the human intestinal lamina propria. (1988) (47)
- Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease. (1992) (47)
- Impact of Abdominal Visceral Adipose Tissue on Disease Outcome in Pediatric Crohn's Disease (2014) (46)
- A pleiotropic missense variant in SLC 39 A 8 is associated with Crohn ’ s disease and human gut microbiome composition Short Title : SLC 39 A 8 associated with CD and gut microbiome (2016) (46)
- Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 pathways. (1996) (46)
- Regulation of ICAM-1-mediated fibroblast-T cell reciprocal interaction: implications for modulation of gut inflammation. (1999) (45)
- Mechanisms of Tissue Remodeling in Inflammatory Bowel Disease (2013) (44)
- Production of IL-1beta, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis. (2005) (43)
- Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors. (1988) (43)
- Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease (2013) (41)
- Crohn’s Disease Fibroblasts Overproduce the Novel Protein KIAA1199 to Create Proinflammatory Hyaluronan Fragments (2016) (41)
- Acid-Induced Release of Platelet-Activating Factor by Human Esophageal Mucosa Induces Inflammatory Mediators in Circular Smooth Muscle (2006) (39)
- Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. (2005) (39)
- Acupuncture in Inflammatory Bowel Disease. (2018) (39)
- Critical role of caspases in the regulation of apoptosis and proliferation of mucosal T cells. (2002) (38)
- Pathogenesis of postoperative recurrence in Crohn's disease (2010) (38)
- Redox Equilibrium in Mucosal T Cells Tunes the Intestinal TCR Signaling Threshold1 (2005) (38)
- Antifibrogenic Effects of the Antimicrobial Peptide Cathelicidin in Murine Colitis-Associated Fibrosis (2014) (37)
- What is "physiological" intestinal inflammation and how does it differ from "pathological" inflammation? (2008) (37)
- Closing fistulas in Crohn's disease--should the accent be on maintenance or safety? (2004) (37)
- Amino Acid Position 11 of HLA-DRβ1 is a Major Determinant of Chromosome 6p Association with Ulcerative Colitis (2011) (36)
- Immune events associated with inflammatory bowel disease. (1990) (36)
- Breaking the therapeutic ceiling in drug development in ulcerative colitis. (2021) (35)
- Identification of Endothelial-to-Mesenchymal Transition as a Potential Participant in Radiation Proctitis. (2015) (34)
- The immune system in inflammatory bowel disease. (1997) (34)
- Inflammatory bowel disease pathogenesis: therapeutic implications. (2005) (34)
- HCl-induced inflammatory mediators in cat esophageal mucosa and inflammatory mediators in esophageal circular muscle in an in vitro model of esophagitis. (2006) (33)
- Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease. (2012) (31)
- Sequential and rapid activation of select caspases during apoptosis of normal intestinal epithelial cells. (1998) (31)
- Progress in basic inflammatory bowel disease research. (2007) (31)
- Regulation of life and death in lamina propria T cells. (2001) (30)
- Susceptibility Genes and Overall Pathogenesis of Inflammatory Bowel Disease: Where Do We Stand? (2009) (29)
- Layilin is critical for mediating hyaluronan 35kDa-induced intestinal epithelial tight junction protein ZO-1 in vitro and in vivo. (2017) (29)
- The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis. (2014) (29)
- Drug development in IBD: from novel target identification to early clinical trials (2016) (29)
- Cytokines and animal models: a combined path to inflammatory bowel disease pathogenesis. (1993) (29)
- The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. (2009) (29)
- Gene–gene and gene–environment interactions in ulcerative colitis (2014) (29)
- Dual Function of the Extracellular Matrix: Stimulatory for Cell Cycle Progression of Naive T Cells and Antiapoptotic for Tissue-Derived Memory T Cells1 (2004) (28)
- Cytokines and intestinal inflammation. (1996) (28)
- Inflammatory bowel disease: dogmas and heresies. (2002) (28)
- Paradoxical decrease of mitochondrial DNA deletions in epithelial cells of active ulcerative colitis patients. (2004) (27)
- IL-36 in chronic inflammation and fibrosis - bridging the gap? (2021) (27)
- Life and death in the gut: more killing, less Crohn's (2002) (27)
- Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy. (2002) (27)
- Probiotic Sonicates Selectively Induce Mucosal Immune Cells Apoptosis through Ceramide Generation via Neutral Sphingomyelinase (2011) (26)
- Integrating Omics: The Future of IBD? (2014) (26)
- News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010. (2010) (25)
- Selective deletion of MyD88 signaling in α-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation (2020) (25)
- Lymphokines and the intestinal immune response. Role in inflammatory bowel disease. (1989) (24)
- Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. (2005) (24)
- A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications (2016) (24)
- Genes and ‘In-Vironment’: How Will Our Concepts on the Pathophysiology of Inflammatory Bowel Disease Develop in the Future? (2013) (24)
- A Novel Approach to Detect Cumulative Genetic Effects and Genetic Interactions in Crohn’s Disease (2013) (24)
- From immune activation to gut tissue injury: the pieces of the puzzle are coming together. (1999) (23)
- Production of inflammatory cytokines in the intestinal lamina propria (1991) (23)
- Platelet‐activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non‐erosive reflux disease patients and controls (2012) (23)
- Cytokine production in the human gastrointestinal tract during inflammation (1994) (23)
- HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. (2010) (22)
- In vitro model of acute esophagitis in the cat. (2003) (22)
- What's new in IBD therapy: an "omics network" approach. (2020) (21)
- Inflammatory Bowel Disease: Complexity and Variability Need Integration (2018) (21)
- Inflammatory Bowel Disease-Associated Gene Expression in Intestinal Epithelial Cells by Differential cDNA Screening and mRNA Display (2003) (21)
- Inflammatory bowel disease: new insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy. (2004) (20)
- The normal intestinal mucosa: a state of ‘controlled inflammation’ (2003) (20)
- Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa (1996) (20)
- Inflammatory bowel disease : diagnostic and therapeutic strategies (2007) (20)
- Intestinal Fibroblast-Derived IL-10 Increases Survival of Mucosal T Cells by Inhibiting Growth Factor Deprivation- and Fas-Mediated Apoptosis 1 (2005) (20)
- Isolation of Human Intestinal Mucosal Mononuclear Cells (1996) (20)
- Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease. (1998) (20)
- Tumor-infiltrating lymphocytes: new therapy, new hopes. (1990) (19)
- Characterization of PTPN2 and its use as a biomarker. (2014) (18)
- Towards a ‘Cure’ for IBD (2012) (18)
- Novel mechanisms and clinical trial endpoints in intestinal fibrosis * (2021) (18)
- Alterations of mesenchymal and endothelial cells in inflammatory bowel diseases. (2006) (17)
- IBD: advances in pathogenesis, complications, diagnosis, and therapy. (2012) (17)
- Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease (1981) (17)
- Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease. (2021) (17)
- Chromosome-associated protein D3 promotes bacterial clearance in human intestinal epithelial cells by repressing expression of amino acid transporters. (2015) (17)
- One commensal bacterial molecule--all we need for health? (2005) (16)
- Atherosclerosis and inflammatory bowel disease: sharing a common pathogenic pathway? (2003) (16)
- Editorial: Gene–Gene Interactions in Inflammatory Bowel Disease: Biological and Clinical Implications (2009) (15)
- Endothelial Cell-Immune Cell Interaction in IBD (2016) (15)
- Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD - what, why, and how. (2021) (15)
- Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis ‐ a unique therapeutic target in inflammatory bowel disease (2021) (14)
- Expression of HLA-DR antigens in inflammatory bowel disease mucosa: Role of intestinal lamina propria mononuclear cell-derived interferon γ (1988) (14)
- Inflammatory bowel disease: evolutionary concepts in biology, epidemiology, mechanisms and therapy. (2013) (14)
- (2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease. (1985) (13)
- M1186 Endothelial-to-Mesenchymal Transition of Intestinal Mucosal Microvascular Cells: A Novel Mechanism of Intestinal Fibrosis (2008) (13)
- Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn’s disease (2021) (13)
- Pitfalls in cytokine analysis in inflammatory bowel disease. (1996) (13)
- Network Medicine: A Mandatory Next Step for Inflammatory Bowel Disease. (2018) (12)
- Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients. (2000) (12)
- Gut mucosal lymphocytes in inflammatory bowel disease (1979) (12)
- Crohn's disease and ulcerative colitis mucosal T cells are stimulated by intestinal epithelial cells: implications for immunosuppressive therapy. (1997) (12)
- Targeting the innate immune system in pediatric inflammatory bowel disease (2011) (12)
- Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy. (2018) (11)
- Cytokines in Inflammatory Bowel Disease (1996) (11)
- Etiopathogenesis of infl ammatory bowel diseases (2006) (11)
- Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA (1995) (11)
- Interferon γ production by human intestinal mucosal mononuclear cells (1988) (11)
- Lymphokine-activated killer (LAK) cells from human intestinal mucosa: cytotoxic activity against tumor cell lines and modified self but not autologous and allogeneic colon cancer cells. (1988) (11)
- Tailoring Treatment to the Individual Patient - Will Inflammatory Bowel Disease Medicine Be Personalized? (2015) (11)
- Activation of Toll-Like Receptor (TLR) 5 Induces a PRO-Fibrogenic Phenotype on Human Intestinal Myofibroblasts (HIF) – A Novel Pathway Mediated by Caspase 1 (2011) (11)
- Complete Genome Sequence of a Parabacteroides distasonis Strain (CavFT hAR46) Isolated from a Gut Wall-Cavitating Microlesion in a Patient with Severe Crohn’s Disease (2019) (10)
- Immunology of inflammatory bowel disease. (1991) (10)
- Pharmacokinetic Evaluation of Oral Levofloxacin in Human Immunodeficiency Virus-Infected Subjects Receiving Concomitant Antiretroviral Therapy (2001) (10)
- Probiotics in inflammatory bowel disease: yet another mechanism of action? (2006) (10)
- Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease. (2000) (9)
- The multiple components of inflammatory bowel disease pathogenesis: Should we invest in all of them or should we pick and choose?: Editorial review (2005) (8)
- Microbial Factors in the Pathogenesis of IBD (2003) (8)
- IBD Systems Biology Is Here to Stay. (2021) (8)
- Early and late inflammatory bowel disease: why and how are they different? (2011) (8)
- Modulation of intestinal immune reactivity by interleukin 2 (1988) (7)
- Eosinophilic esophagitis: new insights into an emerging disease. (2006) (7)
- "Immune/Non-immune cell interactions in intestinal inflammation" workshop. (1997) (7)
- Overview of Inflammatory Bowel Disease Pathogenesis (1990) (7)
- Future of IBD pathogenesis: how much work is left to do? (2008) (7)
- 192 Pro-Fibrogenic Activity of Toll-Like Receptor (TLR) and NOD-Like Receptor (NLR) Ligands on Human Intestinal Myofibroblasts (HIF) – Linking Bacterial Innate Immunity to Intestinal Fibrosis (2010) (7)
- 573 Adipocyte and Preadipocyte Derived-Mediators Induce a PRO-Fibrogenic Phenotype in Human Intestinal Mesenchymal Cells -A Novel Link Between Fat and Intestinal Fibrosis (2014) (6)
- Essential role of the CD40 pathway in T-cell-mediated induction of chemokines and cell adhesion molecules by human intestinal fibroblasts (HIF) and microvascular endothelial cells (HIMEC) (2001) (6)
- Lymphoid cells of the gastrointestinal tract. Isolation procedures. (1985) (6)
- Cytokines: Opportunities for Therapeutic Intervention (2000) (6)
- Early versus late immune mediated inflammatory diseases. (2011) (6)
- More answers and more questions in inflammatory bowel disease. (2003) (6)
- DISTINCT MUCOSAL T-CELL RESPONSES TO IL-12 IN EARLY AND LATE STAGES OF INFLAMMATORY BOWEL DISEASE (IBD) (1998) (5)
- Starving the inflamed gut: Angiogenesis blockade as a novel therapeutic approach to experimental colitis (2006) (5)
- Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change? (2022) (5)
- Gut Immunity and Inflammatory Bowel Disease (2008) (5)
- Collagen synthesis by human intestinal fibroblasts (HIF) is modulated by T-cells through the CD40/CD40 ligand (CD401) pathway (2001) (5)
- Sa2018 - Radiomic Texture Analysis Shows Differential Expression within Visceral Adipose Tissue Regions on MRI Reflecting Severity of Pediatric Crohn's Disease (2018) (5)
- Interleukin 1B-induced reduction of Les tone (2000) (5)
- Intestinal Mucosal Lymphocytes: A New Approach to the Pathogenesis of Inflammatory Bowel Disease (1986) (5)
- Resident research award: tumor necrosis factor alpha selectively enhances growth and cytotoxic activity of tumor infiltrating lymphocytes from human colorectal cancer. (1992) (5)
- Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study. (2022) (5)
- A novel murine model of chronic inflammation-induced intestinal fibrosis (2000) (5)
- 598 Eosinophil Derived TGF-ß1 Activates Human Esophageal Mesenchymal Cells and Alters Esophageal Motility - Implications for Dysphagia in Eosinophilic Esophagitis (EoE) (2012) (4)
- A Model Integrating Genetic and Environmental Factors Interactions Can Predict Crohn’s Disease Risk: 1701 (2014) (4)
- Loss of anchorage leads to extensive apoptosis of human intestinal epithelial cells (IEC), independent of their location on the crypt-villus axis or the mode of isolation (1998) (4)
- Su1869 Submucosal Fibrosis in Ulcerative Colitis Is Linked With Severity and Chronicity of Inflammation (2016) (4)
- A Specific Breath Metabolome Signature Identifies Patients With Inflammatory Bowel Diseases: 1842 (2015) (4)
- 629 - Creeping-Fat Derived Free Fatty Acids Induce Hyperplasia of Intestinal Muscularis Propria Muscle Cells – A Novel Link Between Fat and Intestinal Stricture Formation in Crohn's Disease (2018) (3)
- Imbalance of BCL-2 family protein expression by mucosal T-cells favors resistance to apoptosis in Crohn's disease (CD) (1998) (3)
- More Clues to the Relationship Between Hepatic Iron and Steatosis: An Association With Insulin Resistance? (1999) (3)
- Inflammatory bowel disease: genetics and much more. (2002) (3)
- T cell receptor vβ gene expression in inflammatory bowel disease lamina propria lymphocytes: evidence for altered vβ gene usage. (1995) (3)
- Late‐breaking news from the “4th International Meeting on Inflammatory Bowel Diseases” Capri, 2006 (2007) (3)
- Alimentary tract andpancreas Immunoregulatory function ofhumanintestinal mucosa lymphoid cells: evidence forenhanced suppressor cell activity ininflammatory bowel disease (1983) (3)
- Proliferative Responses of Gut Mucosal Lymphocytes from Crohn’s Disease Patients to Enterobacterial Common Antigen, Lipopolysaccharide and Cell Wall-Defective Bacteria (1981) (3)
- Inflammatory bowel disease: an immunological overview (1992) (3)
- Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction. (2019) (3)
- 359 Stimulation of Lymphatic Function via VEGFR-3 as a Novel Therapy for Chronic Experimental Intestinal Inflammation (2012) (2)
- A central role for Il-10 in the anti-apoptotic effect of human intestinal fibroblasts (HIF) on mucosal T-cells (2001) (2)
- IBD: the need for sweeping new concepts in pathogenesis and therapy. (2017) (2)
- Inflammatory bowel disease (2002) (2)
- [Molecular genetic detection of polyclonal immune response in autoimmune thyroiditis and inflammatory bowel diseases]. (1989) (2)
- IBD: Progress in Pathogenesis (1993) (2)
- New concepts of pathogenesis in IBD (1994) (2)
- 887 Integrated Pathways of Fibrogenesis in Eosinophilic Esophagitis: Active Secretion of Th2 Cytokines and TGF-β1, and Binding of Activated Eosinophils Promote Collagen I and Fibronectin Production By Human Esophageal Mesenchymal Cells (2009) (2)
- T1691 Lack of Tolerization and Cross-Tolerization of Intestinal Mesenchymal and Endothelial Cells to Bacterial Products and TNF-α: A Novel Mechanism to Sustain and Amplify Gut Inflammation (2009) (1)
- (2'-5')Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients. (1988) (1)
- Falling from grace: paradigm shifting in inflammatory bowel disease (2007) (1)
- Tu1279 FLAGELLIN-INDUCED CASPASE-1 ACTIVATION OF HUMAN INTESTINAL MYOFIBROBLASTS DRIVES PRODUCTION OF FIBRONECTIN – A NOVEL, TARGETABLE MECHANISM OF INTESTINAL FIBROSIS (2020) (1)
- Falk Symposium Series (2009) (1)
- Non-stop progress in inflammatory bowel disease: new players, new understanding, new therapies. (2006) (1)
- Letter: volatile metabolomics of exhaled breath or faecal gas? – authors' reply (2015) (1)
- Su1908 – A Validated Serum Headspace Metabolome Profile Discriminates Crohn’s Disease from Non-Crohn’s Disease (2019) (1)
- Fas-CD45RO-negative T-cells contribute to mucosal T-cell resistance to apoptosis in Crohn's disease (CD) (1998) (1)
- The Breath Metabolome in Patients With Pouch Disorders: 1879 (2015) (1)
- Inflammatory Bowel Disease Therapy: Beyond the Immunome (2022) (1)
- The inflammatory cytokines IL-1β and IL-6 inhibit neurally-mediated but not myogenic contraction of cat esophagus (1998) (1)
- TRPV1-Induced ATP Production by Human Esophageal Epithelial Cells Mediates Release of CGRP and Substance P From Esophageal Mucosa (2011) (1)
- Subclinical intestinal inflammation and immune abnormalities in healthy relatives of Crohn's disease (CD) patients* (2001) (1)
- Chapter 12 – Eosinophil-Mediated Tissue Remodeling and Fibrosis (2013) (1)
- IL-12 receptor β2 chain upregulation in mucosal tcells in early but not late Crohn's disease (CD): implications for variable IFN-γ production during disease progression (1998) (1)
- 25 IDENTIFICATION OF PATHOGENIC BACTERIA IN SEVERE CROHN’S DISEASE (2019) (1)
- P285 - Mucosal nonimmune cells produce pro-inflammatory mediators in response to Toll-like (TLRs) and Nod-like receptor (NLRs) ligands: mesenchymal and endothelial cells as novel players of intestinal innate immunity (2009) (1)
- ICAM-1 antisense disrupts intestinal fibroblast-T-cell interaction: Implications for modulation of intestinal inflammation (1998) (1)
- Genetics of IBD: impact on immune function (2000) (1)
- Tu1280 SUCCESSFUL ESTABLISHMENT OF DECELLULARIZED INTESTINAL EXTRACELLULAR MATRIX 3D SCAFFOLDS WITH PRESERVED STRUCTURE, COMPONENTS AND FUNCTION (2020) (1)
- Ulcerative colitis (UC) and Crohn's disease (CD) tissue gene expression profiling by DNA microarrays: Diagnostic and therapeutic implications (2000) (1)
- First international summit on fibrosis in intestinal inflammation: mechanisms and biological therapies (2010) (1)
- Oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease (1)
- Corrigendum to: Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction. (2019) (1)
- Role of Interferon in the Pathogenesis of Inflammatory Bowel Disease (1986) (1)
- Automated segmentation and radiomic characterization of visceral fat on bowel MRIs for Crohn's disease (2018) (1)
- CEACAM1-Mediated Angiogenesis by Activation of Toll-Like (TLR) and NOD-Like (NLR) Receptors of Human Intestinal Mucosal Endothelial Cells in IBD (2011) (1)
- Distinct T-cell cycling of human intestinal lamina propria (LPT) and peripheral blood cells (PBT) may explain the hyperresponsiveness of LPT to CD2 activation (2001) (1)
- The Biological Response Modifiers Interleukin-2 and Tumor Necrosis Factor-α Modulate the Cytotoxic Activity of Tumor Infiltrating Lymphocytes Against Human Colon Cancer Cells (1992) (1)
- Resistance of Crohn's disease (CD) mucosal T-cells to cell death is independent of trigger: Decreased anti-Fas and nitric oxide (NO)-induced apoptosis (1998) (1)
- O-030 YI Toll-like Receptor (TLR) 5 Promotes a Pro-fibrogenic Phenotype in Human Intestinal Fibroblasts (HIF) via MyD88, Caspase-1 and Posttranscriptional Regulation (2013) (1)
- Loss of vasoactive intestinal polypeptide immunoreactive nerve fibres in the colon of IBD patients (1990) (1)
- Immune Based Therapies for Inflammatory Bowel Disease (2016) (1)
- Adipokine Resistin Levels at Time of Pediatric Crohn Disease Diagnosis Predict Escalation to Biologic Therapy. (2020) (1)
- HCL-Induced Production of Cytokines by Human Esophageal Epithelial Cells (2011) (0)
- Multifaceted progress in mechanisms and therapy of inflammatory bowel disease (2001) (0)
- Gene–gene and gene–environment interactions in ulcerative colitis (2013) (0)
- 504 Induction of Angiogenesis by Distinct Toll-Like (TLR) and NOD-Like (NLR) Receptors: Evidence for Bacteria-Mediated Angiogenesis in IBD (2010) (0)
- 638 Toll-Like (TLR) and NOD-Like (NLR) Receptor Activation of Mucosal Endothelial Cells Upregulates Ceacam1 Expression and Induces Ceacam1-Mediated Angiogenesis (2010) (0)
- Ulcerative colitis (UC) and Crohn's disease (CD) tissue gene expression profiling by DNA microarray techniques: Diagnostic and therapeutic implications (2000) (0)
- Expression of T Cell Protein Tyrosine Phosphatase (PTPN2) is Enhanced in Mucosal T Cells in IBD Patients (2011) (0)
- Intestinal TCR Signaling Threshold Redox Equilibrium in Mucosal T Cells Tunes (2005) (0)
- Human Intestinal Myofibroblasts DepositED COLLAGEN VI EnhanceS Adhesiveness for T cells - A Novel Mechanism for Maintenance of Intestinal Inflammation. (2022) (0)
- Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients (2011) (0)
- Numbers Do Not Lie: The Dire Need for New Directions in IBD. (2022) (0)
- Su2012 Impact of Abdominal Visceral Adipose Tissue on Disease Outcome in Pediatric Inflammatory Bowel Disease (2013) (0)
- Activated platelets contribute to inflammatory bowel disease (IBD) pathogenesis through release of rantes which mediates T-cell adhesion to intestinal microvascular endothelial cells (HIMEC) (2003) (0)
- W1847 Increased Matrix Stiffness Induces a Fibrogenic Phenotype in Human Colonic Mesenchymal Cells (2010) (0)
- T1681 Inflammation-Induced Mucosal Endothelial-to-Mesenchymal Transition (EndoMT): A Novel Mechanism Contributing to the Development of Intestinal Fibrosis (2009) (0)
- InflammationAdaptive Immunity, Coagulation, and Endothelial Cells: Directing Innate and Immune Regulation by Microvascular (2007) (0)
- and late inflammatory bowel disease Mucosal T-cell immunoregulation varies in early (2008) (0)
- STAT3 signaling pathway: an essential mediator of inflammatory bowel disease and other form of intestinal infiammation (2005) (0)
- S23 Induction of angiogenesis by distinct Nod-like (NLR) and Toll-like (TLR) receptors: Linking innate immunity to bacteria and angiogenesis in IBD (2010) (0)
- 871 Eosinophilic Esophagitis (EoE)-Associated Eosinophil Products and Cytokines Reduce Neurogenic Esophageal Smooth Muscle Contractility (2010) (0)
- Crucial role of vegf in IBD : at the cross-road between immune-driven angiogenesis and inflammation (2007) (0)
- T Cell Receptor V&bgr; Gene Expression in Inflammatory Bowel Disease Lamina Propria Lymphocytes: Evidence for Altered V&bgr; Gene Usage (1995) (0)
- Inflammatory bowel disease summit October 4-7, 2006 : Intercontinental hotel & MBNA conference center Cleveland, Ohio (2006) (0)
- angiogenesis in inflammatory bowel disease regulating mucosal inflammation-driven Critical role of the CD40CD40-ligand pathway in (2008) (0)
- Induction of Mucosal Inflammation by Danger-Associated Molecular Patterns (DAMPs): Intestinal Epithelial Cell (IEC)-Derived IL-1α as a New Player in the Pathogenesis of IBD (2011) (0)
- Mucosal integrity and apoptosis: Efficient and rapid execution of programmed cell death in primary human intestinal epithelial cells which die of apoptosis as they reach the intestinal lumen (2000) (0)
- Caspase 3 family members mediate the cleavage of focal adhesion kinase (FAK) but not related adhesion focal tyrosine kinase (RAFTK) during detachment-induced apoptosis of human intestinal epithelial cells (IEC) (1998) (0)
- 912 Increased Expression of T Cell Protein Tyrosine Phosphatase (Tc-Ptp) PTPN2 by Mucosal T Cells in IBD Patients (2010) (0)
- Current perspectives in inflammatory bowel disease: stress response and autophagy, host-microbe mutualism, immune duality and plasticity, and early versus late disease. (2010) (0)
- approach to experimental colitis Angiogenesis blockade as a new therapeutic (2008) (0)
- Current Opinion in Gastroenterology: Editorial introductions (2010) (0)
- Pathogenic Mechanisms in Inflammatory Bowel Disease (2000) (0)
- P093 Creeping fat-derived long chain free fatty acids drive intestinal muscularis propria muscle cell proliferation via carnitine palmitoyltransferase 1 (CPT-1) – a relevant mechanism for stricturing Crohn’s disease (2023) (0)
- P284-Pathology of regulatory T cells in Crohn's disease: impaired migration of CCR4+ Treg to inflamed mucosa or insufficient priming of naive Treg in the mesenteric lymph node – or both? (2009) (0)
- Sa1789 - Serum Headspace Metabolome Analysis Discriminates Crohn's Disease from Controls with High Accuracy and is Linked to Disease Phenotypes (2018) (0)
- W1584 Corticotropin Releasing Hormone Family Peptides Regulate Intestinal Angiogenesis (2009) (0)
- Neurotensin-HIF-1a-microRNA-210 Axis Orchestrates Hypoxia, Colonic Inflammation and Intestinal Angiogenesis (2013) (0)
- Bringing It Altogether: A Systems Biology Approach to Biomarkers in Inflammatory Bowel Disease (2019) (0)
- Opportunities in Pediatric IBD Research: Updating the Scientific Agenda (2006) (0)
- Induction of Colitis in Mice and Overexpression of VEGF-A and sVEGFR-1 Using Adenovirus Colitis (2009) (0)
- Immunology of the Gastrointestinal Tract (1980) (0)
- P-150 Analysis of the Breath Metabolome for the Diagnosis and Differentiation of Inflammatory Bowel Disease: A Pilot Study (2013) (0)
- Stimulation of CD2-activated mucosal T cells by intestinal epithelial cells (IEC) requires LFA-3 and is independent of MHC class II and B7 (1998) (0)
- S15 Aryl hydrocarbon receptor signaling protects mice from inflammatory bowel disease (2010) (0)
- 937 A POSITIVE FEEDBACK LOOP BETWEEN CREEPING FAT AND INTESTINAL STRICTURE FORMATION IN CROHN'S DISEASE: THE ROLE OF CREEPING FAT-DERIVED FREE FATTY ACIDS, EXTRACELLULAR MATRIX, AND INTEGRIN (2020) (0)
- MODULATION OF T CELL REGULATORY FUNCTION BY INTESTINAL FIBROBLASTS: WHERE INFLAMMATION INHIBITS IMMUNE-REGULATION (2009) (0)
- Tu1762 - Inflammation-Activated Intestinal Muscularis Propria Muscle Cells Induce Integrin Mediated Mesenteric Adipocyte and Preadipocyte Migration—A Novel Mechanism for Creeping Fat Formation in Crohn's Disease (2018) (0)
- The VEGF-VEGF receptor pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (2006) (0)
- "Born to die": Molecular mechanisms mediating the rapid induction, amplification and execution of apoptosis in normal human intestinal epithelial cells(IEC) (2000) (0)
- Sa1720 Crohn's Disease Fibroblasts Selectively Overexpress the Novel KIAA1199 Protein That Cleaves Hyaluronan and Generates Pro-Inflammatory Fragments (2014) (0)
- Mucosal t-cell reactivity in children with intestinal inflammation predicts diagnosis of crohn's disease (CD) and ulcerative colitis (uc): 42 (1997) (0)
- Expression characteristics of FOXP3 in peripheral blood and intestinal mucosa of patients with inflammatory bowel disease (2007) (0)
- Sa1738 Paracrine Activity of Necrotic Epithelial IL-1α Mediates Non-Immune Cell Interactions and Amplification of Intestinal Inflammation (2014) (0)
- Report on the seminar for doctoral candidates held at the Palazzo Feltrinelli, October 10-12, 2002 (2003) (0)
- Subject Index Vol. 32, Suppl. 1, 2014 (2014) (0)
- Introduction: First International Symposium on: pediatric inflammatory bowel disease: September 16-18, 2003; Irvington, Virginia, U.S.A. (2005) (0)
- Crohn ' s Disease Anti-Inflammatory Mechanism of Infliximab Microcirculation : A Novel CD 40 / CD 40 L Pathway in the Mucosal Blockade Down-Regulates the α TNF (2006) (0)
- DOP32 Crohn’s disease stricture matrisome analysis reveals the anti-fibrotic activity of milk-fat globule-epidermal growth factor 8 (MFGE8) (2023) (0)
- Changes in signal transduction resulting from focal adhesion kinase (FAK) cleavage during apoptosis of human intestinal epithelial cells (IEC) (1998) (0)
- 30 A NOVEL MECHANISM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR (S1PR) MODULATORS IN INFLAMMATORY BOWEL DISEASES (0)
- 722 INCREASED LEVELS OF CADHERIN-11 EXPRESSION IN IBD PROMOTE FIBROBLAST ACTIVATION AND EXPERIMENTAL INTESTINAL FIBROSIS BUT NOT COLITIS ASSOCIATED CANCER (2021) (0)
- Technical Advance New Isolation Technique to Study Apoptosis in Human Intestinal Epithelial Cells (1998) (0)
- Selective deletion of MyD88 signaling in α-SMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation (2020) (0)
- New Concepts of Pathogenesis in Inflammatory Bowel Disease (1995) (0)
- Su504 FLAGELLIN STIMULATION OF HUMAN INTESTINAL MYOFIBROBLASTS INDUCES CASPASE-1 ACTIVATION DRIVING FIBRONECTIN PRODUCTION – A NOVEL, TARGETABLE MECHANISM OF INTESTINAL FIBROSIS (2021) (0)
- 7 PS CD40 ligand-positive activated platelets contribute directly to inflammatory bowel disease (IBD) pathogenesis through production of IL-8 and rantes (2002) (0)
- P265 - Induction and modulation of T cell regulatory function by intestinal fibroblasts: inhibitory effect of intestinal inflammation (2009) (0)
- T1259 Mucosal Non-Immune Cells Produce Pro-Inflammatory Mediators in Response to Toll-Like (TLRS) and NOD-Like Receptor (NLRS) Ligands: Mesenchymal and Endothelial Cells As Novel Players of the Gut Innate Immunity Response (2008) (0)
- In vitro infection of human intestinal mucosal mononuclear and epithelial cells by the human immunodeficiency virus (HIV). A preliminary report (1990) (0)
- Delivering Precision Medicine and Patient-Centred Care Through a Multidisciplinary Approach (2018) (0)
- P-230 Condensin II: A New Player in the Antimicrobial Response with Links to IBD (2013) (0)
- Epigenetic Modifications Regulate Collagen Type I Alpha 2 (Col1A2) Gene Transcription During Endothelial-to-Mesenchymal Transition (EndoMT) (2011) (0)
- Author Index / Subject Index (2013) (0)
- 626 - Selective Deletion of MYD88 Signaling in α-SMA Positive Cells Ameliorates Experimental Intestinal Fibrosis via Posttranscriptional Regulation (2018) (0)
- LACK OF TOLERIZATION OF INTESTINAL MESENCHYMAL AND ENDOTHELIAL CELLS TO BACTERIAL PRODUCTS AND TNF-α: A NOVEL MECHANISM FOR INTESTINAL CHRONIC INFLAMMATION (2009) (0)
- THE INFLUENCE OF POSTOPERATIVE ADHESIONS AFTER EMERGENCY COLECTOMY WITH STOMA FORMATION ON THE RECONSTRUCTIVE SURGERY (2015) (0)
- Subject Index Vol. 30, Suppl. 3, 2012 (2013) (0)
- Su479 FIBROSTENOTIC CROHN'S DISEASE MESENCHYMAL CELLS ARE RESISTANT TO THE ANTI-FIBROTIC ACTIVITY OF MILK FAT GLOBULE-EGF FACTOR 8 (MFGE8) (2021) (0)
- W1700 Eosinophils and Their Products Activate Human Esophageal Mesenchymal Cells – Implications for Fibrogenesis in Eosinophilic Esophagitis (EoE) (2010) (0)
- Cytokines and inflammatory bowel disease : proceedings from a workshop held at South Lodge Hotel, London, UK, October 1995 (1996) (0)
- Sequential and selective activation of caspases during detachment-induced apoptosis of human intestinal epithelial cells (IEC) (1998) (0)
- Genetic Risk Factors in IBD: Impaired Control of the ‘In-Vironment’? (2013) (0)
- Distinct caspase activities are associated with differential proliferative and apoptotic response of human intestinal lamina propria (LPT) and peripheral blood T-cells (PBT) (2001) (0)
- Current Role of Immunosuppressants in IBD : Special Lecture (2014) (0)
- 505 Epigenetic Regulation of Inflammation-Induced Endothelial-to-Mesenchymal Transition (EndoMT): A Novel Mechanism of Fibrosis in Inflammatory Bowel Disease (IBD) (2010) (0)
- 260 – Identification of Pathogenic Bacteria in Severe Crohn's Disease (2019) (0)
- Amplification Pathway for Immune Response Granular RANTES Release: A Novel CD40-Dependent Platelet Activation and Cutting Edge: T Cells Trigger (2004) (0)
- S13 Inflammation-induced endothelial-to-mesenchymal transition (EndoMT): A novel mechanism of fibrosis in IBD (2010) (0)
- Alterations o f Mesenchyma l and Endothelia l Cells in Inflammator y Bowel Diseases (2006) (0)
- S1704 TNF-α Blockade Inhibits Mucosal T Cell Activation and Cell Cycling and Induces B Cell Apoptosis (2009) (0)
- SARS 2017 Meeting Abstracts. (2017) (0)
- “Gatekeeper” Function of Human Intestinal Microvascular Endothelial Cells (HIMEC) in Leukocyte Interaction (1997) (0)
- 59 HCL-Induced Release of Inflammatory Mediators by the Esophageal Mucosa Stimulates Leukocyte Migration and Production of H2O2 (2010) (0)
- Fas-Mediated Apoptosis Growth Factor Deprivation-and Survival of Mucosal T Cells by Inhibiting Intestinal Fibroblast-Derived IL-10 Increases (2005) (0)
- Tissue Response in Inflammatory Bowel Disease (2006) (0)
- P191 SELECTIVE INDUCTION OF CROHN'S DISEASE (CD) AND ULCERATIVE COLITIS (UC) LAMINA PROPRIA MONONUCLEAR CELLS (LPMC) APOPTOSIS BY PROBIOTICS: INVOLVEMENT OF BACTERIAL SPHINGOMYELINASE (SMAse) (2007) (0)
- State-of-the-Art Lecture: Pathogenesis — why is inflammatory bowel disease increasing in Asia? (2006) (0)
- CADHERIN-11, AN ESSENTIAL REGULATOR OF CELL-CELL ADHESION UPREGULATED IN IBD PATIENTS, PLAYS ESSENTIAL ROLES IN PROMOTING FIBROBLAST ACTIVATION AND DEVELOPMENT OF INTESTINAL INFLAMMATION AND FIBROSIS (2021) (0)
- Su1291 A Selective Breath Metabolome Signature Accurately Differentiates Inflammatory Bowel Disease Patients From Healthy Subjects (2014) (0)
- 416 Eosinophilic Esophagitis Is Associated with Active and Uniform Secretion of Th-2 Cytokines and Reduced Esophageal Smooth Muscle Contractility (2008) (0)
- P-201 Neurotensin-HIF-1&agr;-microRNA-210 Axis Orchestrates Hypoxia, Colonic Inflammation and Intestinal Angiogenesis (2013) (0)
- S1771 TNF-α Blockers Inhibit T Cell Cycling by Notch-1 Signalling (2010) (0)
- State-of-the Art Lecture: The multifactorial pathogenesis of inflammatory bowel disease (2007) (0)
- Tu1795 - Integrating Clinical Factors and a Novel Genetic Risk Variant can Predict Primary Sclerosing Cholangitis Risk in Ulcerative Colitis Patients (2018) (0)
- 864 – Platelets and Their Interaction with Primary Human Intestinal Myofibroblasts Potentiate Extracellular Matrix Generation and Migration- a Novel Pathway for Intestinal Fibrosis (2019) (0)
- Subject Index Vol. 33, Suppl. 1, 2015 (2015) (0)
- Pathophysiology of inflammatory bowel disease (2013) (0)
- Su480 ACTIVATED INTESTINAL MUSCLE PROMOTES PREADIPOCYTE MIGRATION: A NOVEL MECHANISM OF CREEPING FAT FORMATION IN CROHN'S DISEASE (2021) (0)
- 85 DIFFERENTIAL GROWTH AND CLONALITY OF GUT T-CELLS AMONG CROHN'S DISEASE (CD), ULCERATIVE COLITIS (UC), UNDETERMINED INFLAMMATION (NON-IBD) AND CONTROL CHILDREN (1996) (0)
- P043 Induction of mucosal inflammation by Damage-Associated Molecular Patterns (DAMPs): Intestinal Epithelial Cells (IEC) derived IL-1α as a new player in the pathogenesis of IBD (2012) (0)
- 723 INFLAMMATORY BOWEL DISEASE HUMAN INTESTINAL MYOFIBROBLASTS DEPOSIT EXTRACELLULAR MATRIX WITH ENHANCED ADHESIVENESS FOR T-CELLS – A NOVEL MECHANISM FOR MAINTENANCE OF INTESTINAL INFLAMMATION (2021) (0)
- Tu1825 CAP-D3 Promotes Bacterial Clearance in Human Intestinal Epithelial Cells Through Repression of Amino Acid Transporters (2015) (0)
- Mo1761 Mesenteric Fat Cells Induce Proliferation of Intestinal Muscle Cells and Migrate Towards Muscle Cell-Derived Extracellular Matrix Products - A Feedback Loop Explaining the Association of Creeping Fat With Stricture Formation (2015) (0)
- 860 Natural Killer T Cells Bearing IL-13rα2, Producing IL-13 and Having Cytotoxicity for Epithelial Cells Populate the Mucosa in Ulcerative Colitis (2009) (0)
- M1822 Lack of Epigenetic Changes Associated With Tolerized Genes During Sustained Inflammatory Gene Expression by Human Intestinal Fibroblasts (HIF) (2010) (0)
- Su1833 – Elevated Cap-D3 Levels in Intestinal Epithelial Cells Cause Global Chromatin Disorganization and May Have Implications for Crohn’s Disease (2019) (0)
- Novel Gene-Gene and Gene-Environment Interactions in Ulcerative Colitis: ACG IBD Research Award: 1690 (2013) (0)
- Hypo-responsive to CD2-mediated activation by ulcerative colitis (UC), but not Crohn's disease (CD), mucosal T cells (1998) (0)
- Immunological regulation - Clinical and therapeutic implications (1996) (0)
- Su1748 A Novel Approach to Detect Cumulative Genetic Effects and Genetic Interactions in Crohn's Disease (2013) (0)
- Stricturing Crohn’s disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions (2023) (0)
- W2013 The Probiotic Bacillus Polyfermenticus Induces Angiogenesis via An Interleukin-8 (IL-8)/CXCR2-Dependent Mechanism (2009) (0)
- Tissue-Derived Memory T Cells Naive T Cells and Antiapoptotic for Stimulatory for Cell Cycle Progression of Dual Function of the Extracellular Matrix : (2004) (0)
- Tu1274 A NOVEL MECHANISM OF SPHINGOSINE-1-PHOSPHATE RECEPTOR (S1PR) MODULATORS IN INFLAMMATORY BOWEL DISEASES (2020) (0)
- S1287 Radiomic Features on Baseline Magnetic Resonance Enterography Are Prognostic of Disease Severity in Pediatric Crohn’s Disease (2021) (0)
- Sa1878 Intestinal Epithelial Cell (IEC)-Derived IL-1a - a Novel Damage-Associated Molecular Pattern (dAMP) That Initiates and Amplifies IBD (2012) (0)
- 936 CADHERIN-11 IS UPREGULATED IN INFLAMMATORY BOWEL DISEASE PATIENT TISSUES AND FIBROBLASTS AND ITS INHIBITION REDUCES INTESTINAL FIBROSIS (2020) (0)
- W1623 Innate Immunity-Mediated Mucosal Angiogenesis: Induction By Distinct NOD-Like (NLR) and Toll-Like (TLR) Receptors (2009) (0)
- Results of analyses with lactoferrin-repleted granulocytes (2009) (0)
- Pediatrics (Abstracts 1043-1054) (2018) (0)
- Defining the Future of Inflammatory Bowel Disease Care: The Pivotal Role of Personalised Treatment (2019) (0)
- rogress in basic inflammatory bowel disease research (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Claudio Fiocchi?
Claudio Fiocchi is affiliated with the following schools:
